The best of 2019 – an A–Z of infectious diseases research
Take a look at the research highlights of 2019 as we count down the top infectious disease stories from A to Z!
Browsing: Disease Diagnosis
WHO updates HIV testing recommendations
The WHO have updated their recommendations on HIV testing in order to try and expand treatment coverage and reach the people living with HIV who are not yet diagnosed.
Highlights of the Global Tuberculosis Report: more people receive treatment than ever before
In 2018 more people received treatment for tuberculosis than ever before, largely due to improvements in detection and diagnosis, according to the latest Global Tuberculosis Report from the WHO.
US FDA warns of serious liver injury linked to hepatitis C drugs: September’s industry headlines
Take a look at this month’s industry headlines including FDA warnings over hepatitis C drugs in patients with liver injury, a new infectious diseases strategy for the UK and priority review for Merck’s Ebola vaccine.
Novel blood test for tuberculosis could also identify high risk of infection
A novel phage-based blood assay has demonstrated its potential for identifying people at high-risk of developing tuberculosis, in addition to diagnosing established cases.
Quality control in HIV point-of-care testing – an interview with David Padley
In this interview we speak to David Padley from the National Institute for Biological Standards and Control about his recent poster ‘Point-of-Care testing for HIV: specialist quality control materials are a necessity’, presented at ECCMID 2019.
FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines
Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.
Could novel sepsis phenotypes explain clinical trial failures?
New research has identified four novel sepsis phenotypes, suggesting these could be relevant for understanding the heterogeneity of treatment effects and help to explain recent clinical trial failures.
A peek behind the paper – Shailendra K Saxena on pathogen-associated acute encephalitis syndrome (PA-AES)
Take a look behind the scenes of a recent Future Microbiology review, entitled: ‘Pathogen-associated acute encephalitis syndrome: therapeutics and management’, as we ask the authors about the challenges facing this field, the use of complementary and alternative medicine and what research needs to be done.
ECCMID19: Low microbiological testing rates reported in healthcare-associated infections
The ECDC has reported that the burden of healthcare-associated infections is substantial and variability in microbiological testing suggests these infections could be managed better, according to research presented at ECCMID.
